News Digest / Ticker: XGN

Ticker: XGN

10:01am, Tuesday, Jul 29, 2025

Exagen Inc. Reports Q2 2025 Revenue Growth Amid Rising Losses and Operational Challenges

Exagen Inc. (NASDAQ: XGN) - Q2 2025 Financial Overview Exagen Inc. continues its focus on autoimmune diagnostic testing, reporting notable developments and financial results from its Q2 2025 earnings report. The company aims to improve its offering through innovations while navigating financial c...

10:01am, Monday, May 05, 2025

Exagen Inc. Reports Revenue Growth Amid Rising Losses and Declining Cash Reserves in Q1 2025